Volver al ranking

Thumbnails similares a Enlicitide Receives FDA Approval for Hypercholesterolemia Following CORALreef Trials

20 vecinos (thumb_512) · 681 views · HCPLive · Estados Unidos

Enlicitide Receives FDA Approval for Hypercholesterolemia Following CORALreef Trials

HCPLive

@hcplivenews

681Estados Unidos
20Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment

HCPLive

@hcplivenews

374Estados Unidos64
3Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD

HCPLive

@hcplivenews

152Estados Unidos69
14Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026

HCPLive

@hcplivenews

117Estados Unidos64
1How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD

HCPLive

@hcplivenews

109Estados Unidos76
19Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD

HCPLive

@hcplivenews

102Estados Unidos64
2PROACTIVE-HF: Cordella PA Sensor Improves HF Status Regardless of EF

HCPLive

@hcplivenews

100Estados Unidos69
10VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes

HCPLive

@hcplivenews

96Estados Unidos65
7CALIBRATE: Encaleret Achieves Mineral Homeostasis in Patients With ADH1, With Rachel Gafni, MD

HCPLive

@hcplivenews

88Estados Unidos67
11Juana Hutchinson-Colas, MD, OB/GYN

RWJBarnabas Health

@rwjbarnabashealth

86Estados Unidos65
17MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins

HCPLive

@hcplivenews

86Estados Unidos64
5SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma

HCPLive

@hcplivenews

78Estados Unidos69
16Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026

HCPLive

@hcplivenews

68Estados Unidos64
4Crinecerfont Enables Sustained Glucocorticoid Dose Reductions Through 2 Years in Adults With CAH

HCPLive

@hcplivenews

67Estados Unidos69
15Omalizumab vs Oral Immunotherapy for Multifood Allergy

HCPLive

@hcplivenews

65Estados Unidos64
6Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy

HCPLive

@hcplivenews

55Estados Unidos68
18APPs Uniquely Positioned in ILD Collaborative Care

HCPLive

@hcplivenews

31Estados Unidos64
8Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD

HCPLive

@hcplivenews

21Estados Unidos66
9ACC Statement Examines Frailty, Cognitive Impairment, in Cardiovascular Disease

HCPLive

@hcplivenews

17Estados Unidos66
12Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP

HCPLive

@hcplivenews

17Estados Unidos65
13What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD

HCPLive

@hcplivenews

12Estados Unidos65